Proteasome inhibitors to alleviate aberrant IKBKAP mRNA splicing and low IKAP/hELP1 synthesis in familial dysautonomia.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Neurobiology of Disease

• Publication date

  2017-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.nbd.2017.04.009PMID 28404519
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The familial dysautonomia disease gene IKBKAP is required in the developing and adult mouse central nervous system

  2017cited by this paper
• Proteasome inhibitors in cancer therapy: Treatment regimen and peripheral neuropathy as a side effect

  2017cited by this paper
• The Familial Dysautonomia disease gene , Ikbkap / Elp 1 , is required in the developing and adult central nervous system

  2017cited by this paper
• Familial dysautonomia: History, genotype, phenotype and translational research

  2017cited by this paper
• Tocotrienol Treatment in Familial Dysautonomia: Open-Label Pilot Study

  2016cited by this paper
• Loss of Ikbkap Causes Slow, Progressive Retinal Degeneration in a Mouse Model of Familial Dysautonomia

  2016cited by this paper
• Bortezomib for the treatment of multiple myeloma.

  2016cited by this paper
• A practical review on carfilzomib in multiple myeloma

  2016cited by this paper
• Capturing the biology of disease severity in a PSC-based model of familial dysautonomia

  2016cited by this paper
• MicroRNA screening identifies a link between NOVA1 expression and a low level of IKAP in familial dysautonomia

  2016influential reference
• Sensory and autonomic deficits in a new humanized mouse model of familial dysautonomia.

  2016cited by this paper
• Phosphatidylserine Ameliorates Neurodegenerative Symptoms and Enhances Axonal Transport in a Mouse Model of Familial Dysautonomia

  2016cited by this paper
• Profiling olfactory stem cells from living patients identifies miRNAs relevant for autism pathophysiology

  2016cited by this paper
• EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism

  2015cited by this paper
• MicroRNA-101 Suppresses Tumor Cell Proliferation by Acting as an Endogenous Proteasome Inhibitor via Targeting the Proteasome Assembly Factor POMP.

  2015cited by this paper
• Familial Dysautonomia (FD) Human Embryonic Stem Cell Derived PNS Neurons Reveal that Synaptic Vesicular and Neuronal Transport Genes Are Directly or Indirectly Affected by IKBKAP Downregulation

  2015cited by this paper
• A Dynamic Unfolded Protein Response Contributes to the Control of Cortical Neurogenesis.

  2015cited by this paper
• miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database

  2015cited by this paper
• microRNAs as neuroregulators, biomarkers and therapeutic agents in neurodegenerative diseases

  2015cited by this paper
• PathCards: multi-source consolidation of human biological pathways

  2015cited by this paper
• Dimerization of elongator protein 1 is essential for Elongator complex assembly

  2015cited by this paper
• Increased stability of heterogeneous ribonucleoproteins by a deacetylase inhibitor.

  2015cited by this paper
• Proteasome inhibitor carfilzomib complements ibrutinib's action in chronic lymphocytic leukemia.

  2015cited by this paper
• DIANA-miRPath v3.0: deciphering microRNA function with experimental support

  2015cited by this paper
• miRWalk2.0: a comprehensive atlas of microRNA-target interactions

  2015cited by this paper
• Novel Agents for Treatment of Multiple Myeloma

  2015cited by this paper
• Therapeutic landscape of carfilzomib and other modulators of the ubiquitin-proteasome pathway.

  2015cited by this paper
• Rectifier of aberrant mRNA splicing recovers tRNA modification in familial dysautonomia

  2015cited by this paper
• Involvement of IKAP in Peripheral Target Innervation and in Specific JNK and NGF Signaling in Developing PNS Neurons

  2014cited by this paper
• Proteasome inhibitors increase missense mutated dysferlin in patients with muscular dystrophy

  2014cited by this paper
• A neuron autonomous role for the familial dysautonomia gene ELP1 in sympathetic and sensory target tissue innervation

  2014cited by this paper
• DNA damage modulates interactions between microRNAs and the 26S proteasome

  2014cited by this paper
• DIANA-TarBase v7.0: indexing more than half a million experimentally supported miRNA:mRNA interactions

  2014cited by this paper
• Elongator, a conserved complex required for wobble uridine modifications in Eukaryotes

  2014cited by this paper
• Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy

  2014cited by this paper
• Selective and potent Akt inhibition triggers anti-myeloma activities and enhances fatal endoplasmic reticulum stress induced by proteasome inhibition.

  2014cited by this paper
• Novel Agents for the Treatment of Multiple Myeloma: Proteasome Inhibitors and Immunomodulatory Agents

  2013cited by this paper
• MicroRNA-382 expression is elevated in the olfactory neuroepithelium of schizophrenia patients.

  2013cited by this paper
• Structural insights into Elongator function.

  2013influential reference
• Ubiquitination Regulates Expression of the Serine/Arginine-rich Splicing Factor 1 (SRSF1) in Normal and Systemic Lupus Erythematosus (SLE) T Cells*

  2013cited by this paper
• Nutraceutical-mediated restoration of wild-type levels of IKBKAP-encoded IKAP protein in familial dysautonomia-derived cells.

  2012cited by this paper
• MicroRNAs tune cerebral cortical neurogenesis

  2012cited by this paper
• Concise Review: Patient‐Derived Olfactory Stem Cells: New Models for Brain Diseases

  2012cited by this paper
• Proteasome inhibitors: an expanding army attacking a unique target.

  2012cited by this paper
• IKAP/Elp1 Is Required In Vivo for Neurogenesis and Neuronal Survival, but Not for Neural Crest Migration

  2012cited by this paper
• The ubiquitin proteasome system in neurodegenerative diseases: culprit, accomplice or victim?

  2012cited by this paper
• Genome‐wide analysis of familial dysautonomia and kinetin target genes with patient olfactory ecto‐mesenchymal stem cells

  2012cited by this paper
• Low dose proteasome inhibition affects alternative splicing.

  2012cited by this paper
• Nonproteasomal Targets of the Proteasome Inhibitors Bortezomib and Carfilzomib: a Link to Clinical Adverse Events

  2011cited by this paper
• Induced pluripotent stem cells (iPSCs) and neurological disease modeling: progress and promises.

  2011cited by this paper
• IKAP/Elp1 involvement in cytoskeleton regulation and implication for familial dysautonomia.

  2011cited by this paper
• EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment.

  2011cited by this paper
• Effects of IKAP/hELP1 Deficiency on Gene Expression in Differentiating Neuroblastoma Cells: Implications for Familial Dysautonomia

  2011cited by this paper
• Elongator: An Ancestral Complex Driving Transcription and Migration through Protein Acetylation

  2011cited by this paper
• Drug repositioning for orphan diseases

  2011cited by this paper
• Olfactory Stem Cells, a New Cellular Model for Studying Molecular Mechanisms Underlying Familial Dysautonomia

  2010cited by this paper
• microRNAs at the synapse

  2009cited by this paper
• Protective effect against Parkinson's disease-related insults through the activation of XBP1.

  2009cited by this paper
• Modeling Pathogenesis and Treatment of Familial Dysautonomia using Patient Specific iPSCs

  2009cited by this paper
• Elongator controls the migration and differentiation of cortical neurons through acetylation of alpha-tubulin.

  2009cited by this paper
• Deregulated expression of pro-survival and pro-apoptotic p53-dependent genes upon Elongator deficiency in colon cancer cells.

  2008cited by this paper
• Overexpression of endoplasmic reticulum-resident chaperone attenuates cardiomyocyte death induced by proteasome inhibition.

  2008cited by this paper
• A role for ubiquitin in the spliceosome assembly pathway

  2008cited by this paper
• Diversity of degradation signals in the ubiquitin–proteasome system

  2008cited by this paper
• Coupling and coordination in gene expression processes: a systems biology view

  2008cited by this paper
• Elongator complex: how many roles does it play?

  2007cited by this paper
• IKAP/hELP1 deficiency in the cerebrum of familial dysautonomia patients results in down regulation of genes involved in oligodendrocyte differentiation and in myelination.

  2007cited by this paper
• Transcription impairment and cell migration defects in elongator-depleted cells: implication for familial dysautonomia.

  2006cited by this paper
• EGCG corrects aberrant splicing of IKAP mRNA in cells from patients with familial dysautonomia.

  2003cited by this paper
• Tissue-specific reduction in splicing efficiency of IKBKAP due to the major mutation associated with familial dysautonomia.

  2003cited by this paper
• Tocotrienols induce IKBKAP expression: a possible therapy for familial dysautonomia.

  2003cited by this paper
• Rescue of a human mRNA splicing defect by the plant cytokinin kinetin.

  2003cited by this paper
• Purification and Characterization of the Human Elongator Complex*

  2002cited by this paper
• Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia.

  2001cited by this paper
• Familial dysautonomia is caused by mutations of the IKAP gene.

  2001cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• How Proteolysis Drives the Cell Cycle

  1996cited by this paper

• Correction of aberrant splicing of ELP1 pre-mRNA by kinetin derivatives - A structure activity relationship study.

  2024cites this paper
• Elongator promotes neuritogenesis via regulation of tau stability through acly activity

  2022cites this paper
• Elongator and the role of its subcomplexes in human diseases

  2022cites this paper
• The Evolution of Stem Cells, Disease Modeling, and Drug Discovery for Neurological Disorders

  2020cites this paper
• Induced pluripotent stem cells for disease modeling, cell therapy and drug discovery in genetic autonomic disorders: a review

  2019cites this paper
• Antisense oligonucleotides correct the familial dysautonomia splicing defect in IKBKAP transgenic mice

  2018cites this paper
• IKBKAP/ELP1 gene mutations: mechanisms of familial dysautonomia and gene-targeting therapies

  2017cites this paper
• Animal and cellular models of familial dysautonomia

  2017cites this paper